Description | PEGylated liposomes containing MEK inhibitor Mirdametinib (PD0325901). Mirdametinib (PD0325901) is a selective and non ATP-competitive MEK inhibitor with an IC50 of 0.33 nM (cell-free assays). The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only. |
Lipid composition | PEGylated Liposomes |
Liposome Size | 70-120 nm |
Lipid Molar Concentration | 60 mM |
Encapsulated Drug | Mirdametinib PD0325901 |
Drug concentration | 10.0 mg/mL (± ~5%) |
Inside Buffer | 292 mM sucrose, 0.5% DPBS (1X) |
Outside Buffer | 292 mM sucrose, 0.5% DPBS (1X) |
Storage | 2 °C to 8 °C (do not freeze) |
Shelf-life | 3 months |
CAS No. | 391210-10-9 |
Product Name | Catalog | Lipid composition | Liposome Size | Price |
---|---|---|---|---|
Clipos™ Cefixime Encapsulated Liposomes | CDEPG-03 | PEGylated liposomes | 70-120 nm | INQUIRY |
Clipos™ Gilteritinib (ASP2215) Encapsulated Liposomes | CDEPG-19 | HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3 molar ratio) | 70-120 nm | INQUIRY |
Clipos™ Lxabepilone (BMS-247550) Encapsulated Liposomes | CDEPG-20 | PEGylated Liposomes | 70-120 nm | INQUIRY |
Clipos™ Rocaglamide Encapsulated Liposomes | CDEPG-21 | PEGylated Liposomes | 70-120 nm | INQUIRY |
Clipos™ SP600125 Encapsulated Liposomes | CDEPG-22 | PEGylated Liposomes | 70-120 nm | INQUIRY |
Clipos™ Rapamycin (Sirolimus) Encapsulated Liposomes | CDEPG-23 | PEGylated Liposomes | 70-120 nm | INQUIRY |
Clipos™ Lificiguat (YC-1) Encapsulated Liposomes | CDEPG-24 | PEGylated Liposomes | 70-120 nm | INQUIRY |
Clipos™ Eganelisib (IPI-549) Encapsulated Liposomes | CDEPG-25 | PEGylated Liposomes | 70-120 nm | INQUIRY |